Key facts
- This page summarizes Christopher McCarthy's Form 3 filing for INTERPACE BIOSCIENCES, INC. (IDXG).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 03 May 2023, 15:17.
Christopher McCarthy - 21 Apr 2023 Form 3 Insider Report for INTERPACE BIOSCIENCES, INC. (IDXG)
- Reporting relationship
- Principal Financial Officer
- Issuer ticker
- IDXG
- Reported as of
- 21 Apr 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 03 May 2023, 15:17:10 UTC
- Next SEC filing
- 01 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher McCarthy
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Christopher McCarthy filed Form 3 for INTERPACE BIOSCIENCES, INC. (IDXG) on 03 May 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDXG
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,310
- Date
- 21 Apr 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IDXG
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 21 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,500
- Exercise price
- $6.00
- Footnotes
- F1
IDXG
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 21 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,000
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
One-third of the options will vest and become exercisable on 3/10/2022, and the remaining portion will vest and become exercisable in 24 equal monthly installments commencing on the first day of April 2022, subject to continued employment through each such vesting date.
Footnote F2
One-third of the restricted stock units will vest commencing on December 1, 2022 and the remaining two-thirds will vest in equal yearly installments thereafter for the next two years.